Skip to content

Article: Nicotinamide Riboside Administration Improves Mitophagy and Slows Aging in Werner Syndrome: Preclinical Findings

Nicotinamide Riboside Administration Improves Mitophagy and Slows Aging in Werner Syndrome: Preclinical Findings

Nicotinamide Riboside Administration Improves Mitophagy and Slows Aging in Werner Syndrome: Preclinical Findings


Synopsis

Werner syndrome (WS) is a premature aging disease caused by mutations in the WRN gene, which affects DNA repair. WS patients show severe metabolic problems, but the causes are not fully clear, nor is it known if these issues can be treated. This study found that WS patient samples and animal models have low NAD+ levels and impaired mitophagy—the process that removes damaged mitochondria. The WRN gene controls production of an important enzyme (NMNAT1) needed to make NAD+. Restoring NAD+ levels via NR administration improved mitochondrial health and significantly extended lifespan while slowing aging signs in worm and fruit fly models of WS. These results suggest that mitochondrial problems caused by NAD+ loss drive WS aging, and boosting NAD+ may be a promising treatment.

Journal

Nature Communications

Read more

Neurological Health

Nicotinamide Ribosides Improves Aerobic Performance: Preclinical Findings

Synopsis Nicotinamide riboside (NR) is a form of vitamin B3 that helps increase NAD+ and improve mitochondrial function, but its effect on physical fitness is unclear. In a study with sedentary an...

Read more
Cardiovascular Disease

Nicotinamide Riboside Reverses Age-Related Circadian and Mitochondrial Decline: Preclinical Findings

Synopsis Aging disrupts sleep patterns and circadian rhythms, which are linked to metabolic diseases and lower NAD+ levels. This study shows that supplementing with the NAD+ precursor nicotinamide...

Read more